Clinical Trial Update: The Long COVID Treatment Trial [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial for a Long COVID treatment, indicating the study is currently active but not recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Snippet

Sponsor: Scripps Translational Science Institute | Conditions: Long COVID | Phase 2 | Status: ACTIVE_NOT_RECRUITING